✦ LIBER ✦

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

✍ Scribed by N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian

Publisher: Springer
Year: 2010
Tongue: English
Weight: 178 KB
Volume: 284
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-010-1609-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost–effectiveness analysis of adjuvant

Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)

✍ Sang Gyu Lee; Young Geon Jee; Hyun Chul Chung; Sung-Bae Kim; Jungsil Ro; Young-H 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 231 KB

Prospective randomized trial of 5-fluoro

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

✍ Jeffrey M. Albert; Aman U. Buzdar; Reina Guzman; Pamela K. Allen; Eric A. Strom; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 240 KB

Acute arterial thrombosis in a patient w

Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3

✍ C. Theodossiou; G. Kroog; S. Ettinghausen; A. Tolcher; K. Cowan; J. O'Shaughness 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

Adjuvant doxorubicin and cyclophosphamid

Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma : Results of a randomized controlled trial

✍ Soo-Mee Bang; Dae Seog Heo; Ki Hyeong Lee; Jae Ho Byun; Heung Moon Chang; Dong-Y 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

A comparison of cyclophosphamide, adriam

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project

✍ R. V. Smalley; J. Carpenter; A. Bartolucci; C. Vogel; S. Krauss 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Comparative open, randomized, cross-over

Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane® and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC)

✍ H. Rosing; W. W. Ten Bokkel Huinink; R. van Gijn; R. F. M. Rombouts; A. Bult; J. 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 795 KB